To compare Tramadol and Dexmedetomidine in the treatment of shivering after spinal anaesthesia

Not Applicable

Recruiting

• Conditions: ASA I and II; No Pain

• Registration Number: CTRI/2018/03/012732
• Lead Sponsor: Akanksha Bansal

Brief Summary

Shivering after neuraxial blockade should be managed efficiently to reduce its complications. Thus this study would conclude the better drug which can be used in cases of shivering. Also the study will compare the side-effects of the treatment drug and the rate of recurrence after giving the treatment, ultimately reducing the patient discomfort.

**AIM-**

The purpose of this study is to compare Dexmedetomidine 0.5 μg/kg with that of Tramadol 0.5 mg/kg, both diluted in 10 ml NS given as IV infusion in 1 minute, in the treatment of shivering in patients undergoing elective surgery under spinal anaesthesia.

**OBJECTIVE-**

1.To assess the efficacy, potency and side-effects of Tramadol in treatment of shivering

2.To assess the efficacy, potency and side-effects of Dexmedetomidine in treatment of shivering

3.To compare the efficacy, potency and side-effects of both the drugs

Detailed Description

Not available

Study Timeline

• Study Start: 2017-01-01
• Last Update Posted: 2022-06-13

Recruitment & Eligibility

• Status: Open to Recruitment
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

• ASA Grade I and II 2.
• Patients admitted for lower abdominal and lower limb surgeries.

Exclusion Criteria

• Patients with cardiopulmonary disease, hepatic disorder, respiratory and neurological disorder.
• Allergy to the study drugs 3.
• Those with an initial heart rate < 50 beats/minute 4.
• Systolic blood pressure < 100 mmHg 5.
• Patient on narcotics or any other sedatives which alter the thermoregulation 6.
• Patients with recent history of febrile illness and those with history of malignant hyperthermia.
• Contraindication to regional anaesthesia.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
control of shivering	5 minutes

Secondary Outcome Measures

Name	Time	Method
Recurrence of shivering	3 months

Trial Locations

Locations (1)

Peoples Hospital; 🇮🇳 Bhopal, MADHYA PRADESH, India

Peoples Hospital

🇮🇳Bhopal, MADHYA PRADESH, India

Dr Akanksha Bansal

Principal investigator

8435641574

akki.shine@gmail.com